Literature DB >> 9092671

A muscle-specific enhancer within intron 1 of the human dystrophin gene is functionally dependent on single MEF-1/E box and MEF-2/AT-rich sequence motifs.

H J Klamut1, L O Bosnoyan-Collins, R G Worton, P N Ray.   

Abstract

In previous studies we have described a 5.0 kb Hin dIII fragment downstream of muscle exon 1 that exhibits properties consistent with a muscle-specific transcriptional enhancer. The goal of this study has been to identify the sequence elements responsible for muscle-specific enhancer activity. Functional studies indicated that this enhancer is active in pre- and post-differentiated H9C2(2-1) myoblasts but functions poorly in L6 and C2C12 myotubes. The core enhancer region was delimited to a 195 bp Spe I- Acc I fragment and sequence analysis identified three MEF-1/E box and two MEF-2/AT-rich motifs as potential muscle-specific regulatory domains. EMSA competition and DNase footprinting indicated that sequences within a 30 bp region containing single adjoining MEF-1/E box and MEF-2/AT-rich motifs are target binding sites for trans -acting factors expressed in H9C2(2-1) myotubes but not in L6 or C2C12 myotubes. Site-specific mutations within these motifs resulted in a significant reduction in enhancer activity in H9C2(2-1) myotubes. These results suggest that the mechanisms governing DMD gene expression in muscle are similar to those identified in other muscle-specific genes. However, the myogenic profile of enhancer activity and trans -acting factor binding suggests a more specialized role for this enhancer that is consistent with its potential involvement in dystrophin gene regulation in cardiac muscle.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9092671      PMCID: PMC146611          DOI: 10.1093/nar/25.8.1618

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  53 in total

1.  Positive and negative regulatory DNA elements including a CCArGG box are involved in the cell type-specific expression of the human muscle dystrophin gene.

Authors:  H Gilgenkrantz; J P Hugnot; M Lambert; P Chafey; J C Kaplan; A Kahn
Journal:  J Biol Chem       Date:  1992-05-25       Impact factor: 5.157

2.  Morphological, biochemical, and electrophysiological characterization of a clonal cell (H9c2) line from rat heart.

Authors:  J Hescheler; R Meyer; S Plant; D Krautwurst; W Rosenthal; G Schultz
Journal:  Circ Res       Date:  1991-12       Impact factor: 17.367

3.  Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo.

Authors:  A B Lassar; R L Davis; W E Wright; T Kadesch; C Murre; A Voronova; D Baltimore; H Weintraub
Journal:  Cell       Date:  1991-07-26       Impact factor: 41.582

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 5.  The myoD gene family: nodal point during specification of the muscle cell lineage.

Authors:  H Weintraub; R Davis; S Tapscott; M Thayer; M Krause; R Benezra; T K Blackwell; D Turner; R Rupp; S Hollenberg
Journal:  Science       Date:  1991-02-15       Impact factor: 47.728

6.  Distal transcript of the dystrophin gene initiated from an alternative first exon and encoding a 75-kDa protein widely distributed in nonmuscle tissues.

Authors:  J P Hugnot; H Gilgenkrantz; N Vincent; P Chafey; G E Morris; A P Monaco; Y Berwald-Netter; A Koulakoff; J C Kaplan; A Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

7.  Myogenin induces the myocyte-specific enhancer binding factor MEF-2 independently of other muscle-specific gene products.

Authors:  P Cserjesi; E N Olson
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

8.  Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors.

Authors:  Y T Yu; R E Breitbart; L B Smoot; Y Lee; V Mahdavi; B Nadal-Ginard
Journal:  Genes Dev       Date:  1992-09       Impact factor: 11.361

9.  MyoD binds cooperatively to two sites in a target enhancer sequence: occupancy of two sites is required for activation.

Authors:  H Weintraub; R Davis; D Lockshon; A Lassar
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

10.  Dystrophin is transcribed in brain from a distant upstream promoter.

Authors:  F M Boyce; A H Beggs; C Feener; L M Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

View more
  6 in total

1.  The Mef2A transcription factor coordinately regulates a costamere gene program in cardiac muscle.

Authors:  Elizabeth P Ewen; Christine M Snyder; Megan Wilson; Danielle Desjardins; Francisco J Naya
Journal:  J Biol Chem       Date:  2011-07-01       Impact factor: 5.157

2.  Contributions of selective knockout studies to understanding cholinesterase disposition and function.

Authors:  Shelley Camp; Limin Zhang; Eric Krejci; Alexandre Dobbertin; Véronique Bernard; Emmanuelle Girard; Ellen G Duysen; Oksana Lockridge; Antonella De Jaco; Palmer Taylor
Journal:  Chem Biol Interact       Date:  2010-02-11       Impact factor: 5.192

3.  The deacetylase HDAC4 controls myocyte enhancing factor-2-dependent structural gene expression in response to neural activity.

Authors:  Todd J Cohen; Tomasa Barrientos; Zachary C Hartman; Sean M Garvey; Gregory A Cox; Tso-Pang Yao
Journal:  FASEB J       Date:  2008-09-09       Impact factor: 5.191

4.  Myocyte-specific M-CAT and MEF-1 elements regulate G-protein gamma 3 gene (gamma3) expression in cardiac myocytes.

Authors:  Charlene McWhinney; Janet D Robishaw
Journal:  DNA Cell Biol       Date:  2008-07       Impact factor: 3.311

5.  Acetylcholinesterase expression in muscle is specifically controlled by a promoter-selective enhancesome in the first intron.

Authors:  Shelley Camp; Antonella De Jaco; Limin Zhang; Michael Marquez; Brian De la Torre; Palmer Taylor
Journal:  J Neurosci       Date:  2008-03-05       Impact factor: 6.167

6.  G9a inhibits MEF2C activity to control sarcomere assembly.

Authors:  Jin Rong Ow; Monica Palanichamy Kala; Vinay Kumar Rao; Min Hee Choi; Narendra Bharathy; Reshma Taneja
Journal:  Sci Rep       Date:  2016-09-26       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.